什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001920938
申报总市值
US$27.0亿
US$27.0亿
73 檔
36.8%
在 Q3 2025 申报期间,Braidwell LP(CIK: 0001920938)向美国 SEC 提交的 Form 13F 报告显示,其追踪之股票投资组合总市值达 US$27.0亿,共持有 73 个公开申报仓位。
Braidwell LP 在 Q3 2025 进行了结构性的板块轮动与仓位换股。在开立 28 个全新仓位及加仓 15 档持股的同时,亦同步清仓 19 档并减仓 22 档标的。
在资产配置集中度方面,Braidwell LP 的前 5 大核心持股(包含 GH 1.25 02-15-31, CAI, NVCR 0 11-01-25 等)合计占整体申报市值的 36.8%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31债券 | Guardant Health Inc | 债券 | 8.49% | -3.42% | EXIT | |
| 2 | CAI | Caris Life Sciences Inc | 股票-其他 | 6.57% | +0.66% | — | |
| 3 | NVCR 0 11-01-25债券 | Novocure LTD | 债券 | 6.23% | — | +50.08% | |
| 4 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 4.29% | -0.07% | — | |
| 5 | CGON | Cg Oncology Inc | 股票-其他 | 3.92% | -2.22% | EXIT | |
| 6 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.67% | -0.77% | -24.14% | |
| 7 | RGEN 1 12-15-28债券 | Repligen CORP | 债券 | 3.02% | -2.68% | — | |
| 8 | KRYS | Krystal Biotech Inc | 股票-医疗保健 | 2.73% | +0.20% | -28.50% | |
| 9 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.60% | -2.39% | EXIT | |
| 10 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 2.58% | -2.44% | -0.99% | |
| 11 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 2.57% | -1.07% | EXIT | |
| 12 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | 债券 | 2.53% | — | -11.43% | |
| 13 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 2.51% | +0.53% | — | |
| 14 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | 债券 | 2.16% | — | -11.43% | |
| 15 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.95% | -0.05% | +69.17% | |
| 16 | GKOS | Glaukos CORP | 股票-医疗保健 | 1.89% | +0.32% | +29.29% | |
| 17 | DHR | Danaher CORP | 股票-医疗保健 | 1.82% | +0.18% | — | |
| 18 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 1.77% | — | -28.16% | |
| 19 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 1.73% | -0.16% | +45.34% | |
| 20 | APGE | Apogee Therapeutics Inc | 股票-其他 | 1.70% | -1.34% | EXIT | |
| 21 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 1.67% | -1.46% | -60.88% | |
| 22 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.64% | +0.14% | -15.75% | |
| 23 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.52% | — | -17.52% | |
| 24 | ACAD | Acadia Pharmaceuticals Inc | 股票-医疗保健 | 1.51% | -0.30% | — | |
| 25 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.33% | +2.21% | — | |
| 26 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.28% | +1.32% | — | |
| 27 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 1.17% | +0.41% | +37.72% | |
| 28 | IRTC | Irhythm Holdings Inc | 股票-医疗保健 | 1.15% | +0.48% | -24.73% | |
| 29 | PEN | Penumbra Inc | 股票-医疗保健 | 1.06% | -1.15% | EXIT | |
| 30 | KPTI 6 05-13-29 *债券 | Karyopharm Therapeutics | 债券 | 1.04% | — | — | |
| 31 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.02% | -0.26% | -16.58% | |
| 32 | CVS | Cvs Health CORP | 股票-医疗保健 | 0.98% | -0.70% | EXIT | |
| 33 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.97% | -0.38% | — | |
| 34 | CDNA | Caredx Inc | 股票-其他 | 0.94% | +0.03% | — | |
| 35 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 0.85% | -0.94% | EXIT | |
| 36 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 0.85% | — | +101.46% | |
| 37 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.79% | +0.98% | NEW | |
| 38 | RGEN | Repligen CORP | 股票-医疗保健 | 0.78% | +0.70% | +35.35% | |
| 39 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 0.74% | -0.01% | -41.67% | |
| 40 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 0.73% | — | — | |
| 41 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.71% | +1.04% | — | |
| 42 | EXK | Exact Sciences CORP | 股票-原材料 | 0.67% | — | — | |
| 43 | AKRO | Akero Therapeutics Inc | 股票-其他 | 0.67% | — | — | |
| 44 | ATEC | Alphatec Holdings Inc | 股票-其他 | 0.65% | +1.30% | -58.33% | |
| 45 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.61% | +0.20% | — | |
| 46 | VKTX | Viking Therapeutics Inc | 股票-医疗保健 | 0.59% | — | -47.17% | |
| 47 | CSTL | Castle Biosciences Inc | 股票-其他 | 0.56% | — | — | |
| 48 | DRUG | Bright Minds Biosciences Inc | 股票-其他 | 0.55% | -0.05% | — | |
| 49 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 0.53% | — | — | |
| 50 | HROW | Harrow Inc | 股票-其他 | 0.49% | -0.18% | EXIT |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NVCR 0 11-01-25债券 | Novocure LTD | +1.4% | +50.08% | 加仓 |
| 2 | XENE | Xenon Pharmaceuticals Inc | +1.1% | — | 加仓 |
| 3 | CGON | Cg Oncology Inc | +1.1% | — | 不变 |
| 4 | DNTH | Dianthus Therapeutics Inc | +0.7% | — | 加仓 |
| 5 | EWTX | Edgewise Therapeutics Inc | +0.6% | — | 加仓 |
| 6 | GH 1.25 02-15-31债券 | Guardant Health Inc | +0.5% | — | 不变 |
| 7 | NUVL | Nuvalent Inc-a | +0.5% | -13.85% | 加仓 |
| 8 | RGEN | Repligen CORP | +0.4% | +35.35% | 加仓 |
| 9 | CSTL | Castle Biosciences Inc | +0.3% | — | 加仓 |
| 10 | INSP | Inspire Medical Systems Inc | +0.3% | +69.17% | 加仓 |
| 11 | ORKA | Oruka Therapeutics Inc | +0.2% | -9.34% | 减仓 |
| 12 | ✓ | Zura Bio LTD | +0.2% | — | 不变 |
| 13 | ISRG | Intuitive Surgical Inc | +0.2% | +45.34% | 加仓 |
| 14 | KRYS | Krystal Biotech Inc | +0.2% | -28.50% | 加仓 |
| 15 | MRVI | Maravai Lifesciences Hldgs-a | +0.1% | — | 不变 |
| 16 | PEN | Penumbra Inc | 0% | +9.18% | 加仓 |
| 17 | SRPT | Sarepta Therapeutics Inc | -0.1% | — | 加仓 |
| 18 | LUNG | Pulmonx CORP | -0.1% | — | 不变 |
| 19 | REPL | Replimune Group Inc | -0.2% | +550.31% | 加仓 |
| 20 | SYRE | Spyre Therapeutics Inc | -0.2% | — | 不变 |
| 21 | XNCR | Xencor Inc | -0.2% | -24.73% | 减仓 |
| 22 | DXCM 0.25 11-15-25债券 | Dexcom Inc | -0.2% | -27.03% | 减仓 |
| 23 | GKOS | Glaukos CORP | -0.3% | +29.29% | 加仓 |
| 24 | DYN | Dyne Therapeutics Inc | -0.3% | -16.58% | 减仓 |
| 25 | APGE | Apogee Therapeutics Inc | -0.3% | -2.69% | 减仓 |
| 26 | KIDS | Orthopediatrics CORP | -0.4% | — | 不变 |
| 27 | RGEN 1 12-15-28债券 | Repligen CORP | -0.4% | — | 加仓 |
| 28 | HROW | Harrow Inc | -0.4% | -60.75% | 减仓 |
| 29 | DHR | Danaher CORP | -0.4% | — | 不变 |
| 30 | NEO 0.25 01-15-28债券 | Neogenomics Inc | -0.5% | -0.99% | 减仓 |
| 31 | DAWNGBX | Day One Biopharmaceuticals I | -0.5% | — | 减仓 |
| 32 | TMO | Thermo Fisher Scientific Inc | -0.6% | -15.75% | 减仓 |
| 33 | IRTC 1.5 09-01-29债券 | Irhythm Holdings Inc | -0.6% | -11.43% | 减仓 |
| 34 | VKTX | Viking Therapeutics Inc | -0.6% | -47.17% | 减仓 |
| 35 | IRWD 1.5 06-15-26债券 | Ironwood Pharmaceuticals | -0.7% | -11.43% | 减仓 |
| 36 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.8% | -41.67% | 减仓 |
| 37 | TMDX | Transmedics Group Inc | -0.9% | +37.72% | 减仓 |
| 38 | ATEC | Alphatec Holdings Inc | -0.9% | -58.33% | 减仓 |
| 39 | IRTC | Irhythm Holdings Inc | -0.9% | -24.73% | 减仓 |
| 40 | ADPT | Adaptive Biotechnologies | -0.9% | -80.95% | 减仓 |
| 41 | NBIX | Neurocrine Biosciences Inc | -1% | -24.14% | 减仓 |
| 42 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | -1.4% | -74.55% | 减仓 |
| 43 | ALGN | Align Technology Inc | -1.4% | -17.52% | 减仓 |
| 44 | ARGX | Argenx Se - Adr | -1.7% | -60.88% | 减仓 |
| 45 | LEGN | Legend Biotech Corp-adr | -1.8% | -28.16% | 减仓 |
| 46 | CAI | Caris Life Sciences Inc | — | NEW | 新建仓 |
| 47 | SLNOEUR | Soleno Therapeutics Inc | — | NEW | 新建仓 |
| 48 | BBIO 2.5 03-15-27债券 | Bridgebio Pharma Inc | — | EXIT | 清仓 |
| 49 | GH | Guardant Health Inc | — | EXIT | 清仓 |
| 50 | ACAD | Acadia Pharmaceuticals Inc | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案,Braidwell LP 在 Q3 2025 季度的美股持仓总市值约为 US$27.0亿,共申报了 73 个公开持股仓位。
在 Q3 2025 季度,Braidwell LP 按市值排列的前三大核心持股分别为:GH 1.25 02-15-31 (8.5%)、CAI (6.6%)、NVCR 0 11-01-25 (6.2%)。其中最大持股仓位 GH 1.25 02-15-31 占据整体投资组合约 8.5% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CAI
市值: US$2.2亿
本季最大获利了结 / 清仓标的
BBIO 2.5 03-15-27
前期市值: US$7199.7万
在 Q3 2025 季度中,Braidwell LP 共进行了 84 项持仓异动,包含新建仓 28 个仓位、加仓 15 个仓位、减仓 22 个仓位以及清仓 19 个仓位。 其中最大新建仓标的为 CAI。 本季清仓仓位包含 BBIO 2.5 03-15-27。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。